Between January and April 2020, Russia imported 8.4 bln RUB worth of veterinary drugs (customs clearance and VAT included), which is in monetary terms (rubles) 9% lower than in 2019. The dynamics of the import of feed supplements in monetary terms are +12%, with 13.4 bln RUB.

Between January and April 2020, Russia imported 56.7 bln RUB worth of APIs (customs clearance and VAT included), which is in monetary terms (rubles) 60% higher than in 2019. While the average price per 1 kg has increased by nearly 30% (to 12.8 thousand RUB, customs clearance and VAT included), the dynamics in physical terms (kg) are +23%, with the import amounting to 4.4 thousand tons.

Between January and April 2020, Russia imported 108.8 bln RUB worth of ready-made pharmaceutical drugs (customs clearance and VAT included), which is in monetary terms (rubles) 39% lower than in 2019. The in-bulk import amounted to 44.1 bln RUB, with the dynamics of +9%.

The pharmaceutical market is actively preparing for a drop in demand at the moment. At best, the retail dynamics will hardly go beyond stagnation by the end of the year, even though March turned out to be busy. With the stocks replenished during the hype being used now, the consumption curve is already noticeably lower than it usually is at this time of year.

While 61% of Russian doctors question the official COVID-19 death rate in Russia, they do not have evidence of the statistics being manipulated, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Obviously, this reflects both a general distrust of the statistical service in the healthcare system, and purely methodological issues, such as a large number of people who did not experience any symptoms, the quality of the tests and collection of biological materials, etc.